Experiment: 31DM

Holo form of calmodulin-like domain of human alpha-actinin-4

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	1D 1H	0.75 mM [U-100% 13C; U-100% 15N] calmodulin-like domain of human a-actinin-4, 20 mM HEPES, 150 mM NaCl, 2 mM TCEP, 18.75 mM calcium chloride	95% H2O/5% D2O	150 mM	7.4	1 atm	298	Bruker AVANCE NEO 800
2	2D 1H-15N HSQC	0.75 mM [U-100% 13C; U-100% 15N] calmodulin-like domain of human a-actinin-4, 20 mM HEPES, 150 mM NaCl, 2 mM TCEP, 18.75 mM calcium chloride	95% H2O/5% D2O	150 mM	7.4	1 atm	298	Bruker AVANCE NEO 800
3	3D HNCACB	0.75 mM [U-100% 13C; U-100% 15N] calmodulin-like domain of human a-actinin-4, 20 mM HEPES, 150 mM NaCl, 2 mM TCEP, 18.75 mM calcium chloride	95% H2O/5% D2O	150 mM	7.4	1 atm	298	Bruker AVANCE NEO 800
4	3D HN(COCA)CB	0.75 mM [U-100% 13C; U-100% 15N] calmodulin-like domain of human a-actinin-4, 20 mM HEPES, 150 mM NaCl, 2 mM TCEP, 18.75 mM calcium chloride	95% H2O/5% D2O	150 mM	7.4	1 atm	298	Bruker AVANCE NEO 800
5	3D HNCO	0.75 mM [U-100% 13C; U-100% 15N] calmodulin-like domain of human a-actinin-4, 20 mM HEPES, 150 mM NaCl, 2 mM TCEP, 18.75 mM calcium chloride	95% H2O/5% D2O	150 mM	7.4	1 atm	298	Bruker AVANCE NEO 800
6	3D HNCACO	0.75 mM [U-100% 13C; U-100% 15N] calmodulin-like domain of human a-actinin-4, 20 mM HEPES, 150 mM NaCl, 2 mM TCEP, 18.75 mM calcium chloride	95% H2O/5% D2O	150 mM	7.4	1 atm	298	Bruker AVANCE NEO 800
7	3D HBHA(CO)NH	0.75 mM [U-100% 13C; U-100% 15N] calmodulin-like domain of human a-actinin-4, 20 mM HEPES, 150 mM NaCl, 2 mM TCEP, 18.75 mM calcium chloride	95% H2O/5% D2O	150 mM	7.4	1 atm	298	Bruker AVANCE NEO 800
8	3D 1H-15N NOESY	0.75 mM [U-100% 13C; U-100% 15N] calmodulin-like domain of human a-actinin-4, 20 mM HEPES, 150 mM NaCl, 2 mM TCEP, 18.75 mM calcium chloride	95% H2O/5% D2O	150 mM	7.4	1 atm	298	Bruker AVANCE NEO 800
9	2D 1H-13C HSQC	0.75 mM [U-100% 13C; U-100% 15N] calmodulin-like domain of human a-actinin-4, 20 mM HEPES, 150 mM NaCl, 2 mM TCEP, 18.75 mM calcium chloride	95% H2O/5% D2O	150 mM	7.4	1 atm	298	Bruker AVANCE NEO 600
10	3D CCH-TOCSY	0.75 mM [U-100% 13C; U-100% 15N] calmodulin-like domain of human a-actinin-4, 20 mM HEPES, 150 mM NaCl, 2 mM TCEP, 18.75 mM calcium chloride	95% H2O/5% D2O	150 mM	7.4	1 atm	298	Bruker AVANCE NEO 800
11	3D HCCH-TOCSY	0.75 mM [U-100% 13C; U-100% 15N] calmodulin-like domain of human a-actinin-4, 20 mM HEPES, 150 mM NaCl, 2 mM TCEP, 18.75 mM calcium chloride	95% H2O/5% D2O	150 mM	7.4	1 atm	298	Bruker AVANCE NEO 800
12	3D 1H-13C NOESY	0.75 mM [U-100% 13C; U-100% 15N] calmodulin-like domain of human a-actinin-4, 20 mM HEPES, 150 mM NaCl, 2 mM TCEP, 18.75 mM calcium chloride	95% H2O/5% D2O	150 mM	7.4	1 atm	298	Bruker AVANCE NEO 600

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	AVANCE NEO	800
2	Bruker	AVANCE NEO	600

NMR Refinement
Method	Details	Software
simulated annealing, torsion angle dynamics		YASARA

NMR Ensemble Information
Conformer Selection Criteria	all calculated structures submitted
Conformers Calculated Total Number	20
Conformers Submitted Total Number	20
Representative Model	1 (fewest violations)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	refinement	YASARA	14.7.17	YASARA Biosciences GmbH
2	data analysis	NMRFAM-SPARKY	1.2	Lee, W., Tonelli, M., Makley, J. L.
3	processing	ARTINA		Klukowski, P., Riek, R., Guntert, P.
4	collection	TopSpin	4.3	Bruker Biospin
5	peak picking	ARTINA		Klukowski, P., Riek, R., Guntert, P.
6	structure calculation	ARTINA		Klukowski, P., Riek, R., Guntert, P.
7	structure calculation	YASARA	14.7.17	YASARA Biosciences GmbH
8	chemical shift assignment	ARTINA		Klukowski, P., Riek, R., Guntert, P.
10	data analysis	CARA	1.9.1.7	Keller, R., Wuthrich, K.
11	data analysis	TopSpin	4.3	Bruker Biospin
12	processing	TopSpin	4.3	Bruker Biospin
13	peak picking	CARA	1.9.1.7	Keller, R., Wuthrich, K.
14	chemical shift assignment	CARA	1.9.1.7	Keller, R., Wuthrich, K.